Ignite Creation Date:
2024-05-05 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00481273
Status:
COMPLETED
Last Update Posted:
2018-05-03
First Post:
2007-05-30
Brief Title:
AVIDA The Vidaza Azacitidine Patient Registry
Sponsor:
Celgene
Organization:
Celgene
Study Overview
Official Title:
AVIDA The Vidaza Azacitidine Patient Registry
Status:
COMPLETED
Status Verified Date:
2018-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
AVIDA
Brief Summary:
This registry is a prospective multi-center observational study compiling data on the natural history and management of patients receiving Vidaza and will provide unique insights into the management of myelodysplastic syndromes MDS and other hematological disorders and the impact of these disorders on patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None